GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nectar Lifesciences Ltd (BOM:532649) » Definitions » Purchase Of Business

Nectar Lifesciences (BOM:532649) Purchase Of Business : ₹0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Nectar Lifesciences Purchase Of Business?

Nectar Lifesciences's purchase of business for the three months ended in Sep. 2024 was ₹0 Mil. It means Nectar Lifesciences spent ₹0 Mil on purchasing business. Nectar Lifesciences's purchase of business for the trailing twelve months (TTM) ended in Sep. 2024 was ₹0 Mil.

Compared with last quarter (₹0 Mil in Jun. 2024 ), Nectar Lifesciences spent the same money on purchasing business in Sep. 2024 (₹0 Mil).

Nectar Lifesciences Purchase Of Business Historical Data

The historical data trend for Nectar Lifesciences's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nectar Lifesciences Purchase Of Business Chart

Nectar Lifesciences Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Purchase Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Nectar Lifesciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Purchase Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Nectar Lifesciences Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nectar Lifesciences Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Nectar Lifesciences's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Nectar Lifesciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nectar Lifesciences Ltd (BOM:532649) » Definitions » Purchase Of Business
Comparable Companies
BOM:532305 BOM:506414 BOM:524075 BOM:541400 NSE:SAKAR BOM:540937 BOM:532039 BOM:524500 BOM:539730 BOM:506260 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
NECLIFE:India
Address
SCO 38-39, Sector 9-D, B-1011/1012, 10th Floor NAURANG HOUSE, Chandigarh, IND, 160009
Website
https://www.neclife.com
Nectar Lifesciences Ltd is an India-based pharmaceutical company. It is engaged in manufacturing specialized pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and finished dosage formulations. It operates in the business segment of Pharmaceuticals Products, The company's product includes cefixime trihydrate, cefdinir, cefprozil, cefoxitin sodium, cefpirome sulphate, and others. Geographically, it derives a majority of its revenue from India.

Nectar Lifesciences Headlines

No Headlines